Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jervell and Lange-Nielsen Syndrome Related Clinical Genetics and Experimental Models.

Pediatric discovery·2026
Same author

Evolving attitudes towards cancer screening: a 2024 update of UK population views.

British journal of cancer·2026
Same author

Teleconferencing as an alternative to written Advice and Guidance referrals at the primary-secondary care interface: a qualitative case study.

BJGP open·2026
Same author

Finite element modeling of sarcoplasmic reticular intraluminal Ca<sup>2+</sup> diffusional fluxes during amphibian striated muscle excitation-contraction coupling.

Frontiers in physiology·2026
Same author

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project.

Cancers·2026
Same author

Structural implications of glycosylation on the voltage-gated sodium channel β3-subunit.

Journal of structural biology·2026

Related Experiment Videos

Risk stratification for sudden cardiac death.

Ian N Sabir1, Juliet A Usher-Smith, Christopher L-H Huang

  • 1Physiological Laboratory, University of Cambridge, Downing Street, Cambridge, UK. ins20@cam.ac.uk

Progress in Biophysics and Molecular Biology
|April 9, 2009
PubMed
Summary

Identifying patients at risk of sudden cardiac death (SCD) is crucial. Effective risk stratification likely requires combining multiple parameters, with invasive procedures reserved for specific patient groups.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • Sudden cardiac death (SCD) risk management involves pharmacological and device-based therapies.
  • Interventions for SCD risk carry inherent risks, necessitating accurate patient stratification.

Purpose of the Study:

  • To review current and emerging risk stratification measures for sudden cardiac death (SCD).
  • To evaluate the utility of invasive versus non-invasive stratification techniques.

Main Methods:

  • Literature review of risk stratification parameters for sudden cardiac death (SCD).
  • Separate assessment of invasive cardiac catheterization-derived and non-invasive parameters.
  • Analysis of current clinical practice and upcoming market-available tools.

Main Results:

  • Risk stratification for sudden cardiac death (SCD) is increasingly important due to therapeutic advances.
  • Non-invasive techniques offer more accessible stratification compared to invasive cardiac catheterization.
  • Composite parameters are likely essential for effective risk stratification.

Conclusions:

  • Effective sudden cardiac death (SCD) risk stratification may necessitate a combination of parameters.
  • Invasive procedures for risk stratification should be reserved for specific patient subgroups.